Results 11 to 20 of about 106,126 (167)
Indian Journal of Endocrinology and Metabolism, 2019 Background and Aims: Metabolic abnormalities in T2DM (Type 2 diabetes mellitus) include classic manifestations such as impaired insulin secretion, synthesis and peripheral insulin resistance.
Kumaravel Velayutham +5 more
doaj +1 more source
Frontiers in Bioscience-Landmark, 2022 Background: The role of executive functions (EF) is to maintain particular behaviours in order to achieve intended goals. EF are crucial in management of pre-diabetes, diabetes and obesity which are grievous diseases and can lead to severe complications.
Natalia Lesiewska +5 more
doaj +1 more source
Diabetes, Metabolic Syndrome and Obesity, 2022 Muhammed Hassan Nasr,1 Bassam Abdul Rasool Hassan,2 Noordin Othman,3 Mahmathi Karuppannan,4 Noorizan binti Abdulaziz,5 Ali Haider Mohammed,2,6 Mohammed Ahmed Alsarani,7 Mohammed Husain Eskembaji,7 Abdelmannan Mohamed Aman,8 Gamil Othman9 1Clinical ...
Nasr MH +9 more
doaj
Diabetes, Metabolic Syndrome and Obesity, 2021 Amani MT Gusti,1,2 Safaa Y Qusti,1 Suhad M Bahijri,3,4 Eman A Toraih,5,6 Samia Bokhari,7 Sami M Attallah,8,9 Abdulwahab Alzahrani,10 Wafaa MA Alshehri,11 Hawazin Alotaibi,12 Manal S Fawzy13,14 1Department of Biochemistry, Faculty of Science, King ...
Gusti AMT +9 more
doaj
Biomedicines, 2020 A robust and easy-to-use tool for the ex vivo dynamic evaluation of pancreatic islet (PI) function is essential for further development of novel cell-based therapeutic approaches to treating diabetes.
Yonathan Gomez +4 more
doaj +1 more source
SP prevents T2DM complications by immunomodulation [PDF]
Scientific Reports, 2020 AbstractType 2 diabetic mellitus (T2DM) is characterized by systemic inflammation and insulin resistance due to obesity, and this leads to critical complications, including retinopathy and nephropathy. This study explored the therapeutic effect of substance-p (SP), a neuropeptide, on T2DM progression and its complications. To examine whether SP affects
Baek, Sang-Min +5 more
openaire +2 more sources
T2DM/CKD genetic risk scores and the progression of diabetic kidney disease in T2DM subjects
Gene, 2023 Abstract This study explored the predictive value of genetic risk scores (GRS) for diabetic kidney disease (DKD) progression, Major Cardiovascular Events (MCVE), and All-Cause Mortality (ACM) in type 2 diabetes mellitus (T2DM) patients. We assessed 30 T2DM and CKD GWAS-derived single nucleotide polymorphisms (SNPs) in 400 Central European ...
David Galuška +8 more
openaire +3 more sources
Reversal and Remission of T2DM – An Update for Practitioners
Vascular Health and Risk Management, 2022 Over the past 50 years, many countries around the world have faced an unchecked pandemic of obesity and type 2 diabetes (T2DM). As best practice treatment of T2DM has done very little to check its growth, the pandemic of diabesity now threatens to make health-care systems economically more difficult for governments and individuals to manage within ...
Lina Shibib +7 more
openaire +4 more sources
Diabetes, Metabolic Syndrome and Obesity, 2023 Shenghong Qi,1,2 Lan Liu,1,2 Shulan He,1,2 Liqun Wang,1,2 Jiangping Li,1,2 Xian Sun1,2 1School of Public Health and Management, Ningxia Medical University, Yinchuan, Ningxia, People’s Republic of China; 2The Key Laboratory of Environmental Factors and ...
Qi S, Liu L, He S, Wang L, Li J, Sun X
doaj
DIABETES MELLITUS: THE MODERN STATE OF THE ISSUE (PART 1)
Паёми Сино, 2019 The authors analyzed numerous scientific studies on the problem of type 2 diabetes mellitus (T2DM), the extent of the spread is causing concern among experts around the world.
M.U. SHAROFOVA +2 more
doaj +1 more source